These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10898829)

  • 21. An observation study evaluating the efficacy of tazarotene plus corticosteroid in treating plaque psoriasis in patients switched from treatment with calcipotriene +/- corticosteroid.
    Tanghetti EA;
    Cutis; 2000 Dec; 66(6 Suppl):12-8. PubMed ID: 11147086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor-selective retinoids for psoriasis: focus on tazarotene.
    Weindl G; Roeder A; Schäfer-Korting M; Schaller M; Korting HC
    Am J Clin Dermatol; 2006; 7(2):85-97. PubMed ID: 16605289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses.
    Samarasekera EJ; Sawyer L; Wonderling D; Tucker R; Smith CH
    Br J Dermatol; 2013 May; 168(5):954-67. PubMed ID: 23413913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study.
    Rigopoulos D; Gregoriou S; Katsambas A
    Acta Derm Venereol; 2007; 87(2):167-8. PubMed ID: 17340027
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis.
    Tzaneva S; Hönigsmann H; Tanew A; Seeber A
    Br J Dermatol; 2002 Oct; 147(4):748-53. PubMed ID: 12366423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of topical tazarotene monotherapy and combination therapies in psoriasis.
    Koo J; Behnam SE; Behnam SM
    Expert Opin Pharmacother; 2003 Dec; 4(12):2347-54. PubMed ID: 14640932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect.
    Weinstein GD; Krueger GG; Lowe NJ; Duvic M; Friedman DJ; Jegasothy BV; Jorizzo JL; Shmunes E; Tschen EH; Lew-Kaya DA; Lue JC; Sefton J; Gibson JR; Chandraratna RA
    J Am Acad Dermatol; 1997 Jul; 37(1):85-92. PubMed ID: 9216528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and Efficacy of a Fixed Combination Halobetasol and Tazarotene Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Pooled Analysis of Two Phase 3 Studies.
    Sugarman JL; Weiss J; Tanghetti EA; Bagel J; Yamauchi PS; Stein Gold L; Lin T; Martin G; Pillai R; Israel R
    J Drugs Dermatol; 2018 Aug; 17(8):855-861. PubMed ID: 30124724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Instrumental evaluation of retinoid-induced skin irritation.
    Stücker M; Hoffmann M; Altmeyer P
    Skin Res Technol; 2002 May; 8(2):133-40. PubMed ID: 12060479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are topical keratolytic agents needed in the treatment of scalp psoriasis?
    Shokeen D; O'Neill JL; Taheri A; Feldman SR
    Dermatol Online J; 2014 Mar; 20(3):. PubMed ID: 24656276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis.
    Lebwohl M; Ast E; Callen JP; Cullen SI; Hong SR; Kulp-Shorten CL; Lowe NJ; Phillips TJ; Rosen T; Wolf DI; Quell JM; Sefton J; Lue JC; Gibson JR; Chandraratna RA
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):705-11. PubMed ID: 9591815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks.
    Weinstein GD; Koo JY; Krueger GG; Lebwohl MG; Lowe NJ; Menter MA; Lew-Kaya DA; Sefton J; Gibson JR; Walker PS;
    J Am Acad Dermatol; 2003 May; 48(5):760-7. PubMed ID: 12734506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials.
    Gold LS; Lebwohl MG; Sugarman JL; Pariser DM; Lin T; Martin G; Pillai R; Israel R; Ramakrishna T
    J Am Acad Dermatol; 2018 Aug; 79(2):287-293. PubMed ID: 29614243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tazarotene: therapeutic strategies in the treatment of psoriasis, acne and photoaging.
    Roeder A; Schaller M; Schäfer-Korting M; Korting HC
    Skin Pharmacol Physiol; 2004; 17(3):111-8. PubMed ID: 15087589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and safety review of tazarotene.
    Marks R
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S134-8. PubMed ID: 9777791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot study to determine the effect of tazarotene gel 0.1% on steroid-induced epidermal atrophy.
    Kaidbey K; Kopper SC; Sefton J; Gibson JR
    Int J Dermatol; 2001 Jul; 40(7):468-71. PubMed ID: 11679006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of calcipotriene (Dovonex) ointment and tazarotene (Tazorac) gel versus clobetasol ointment in the treatment of plaque psoriasis: a pilot study.
    Bowman PH; Maloney JE; Koo JY
    J Am Acad Dermatol; 2002 Jun; 46(6):907-13. PubMed ID: 12063489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council.
    van de Kerkhof PC; Kragballe K; Segaert S; Lebwohl M;
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1130-9. PubMed ID: 21564329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of tazarotene in the treatment of psoriasis.
    Marks R
    Br J Dermatol; 1999 Apr; 140 Suppl 54():24-8. PubMed ID: 10731131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical agents for the treatment of psoriasis, past, present and future.
    Tremblay JF; Bissonnette R
    J Cutan Med Surg; 2002; 6(3 Suppl):8-11. PubMed ID: 11976984
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.